Evaluation of a simple image‐based tool to quantify facial erythema in rosacea during treatment

por Logger, Jade G. M., de Jong, Elke M. G. J., Driessen, Rieke J. B., van Erp, Piet E. J.
Publicado 2020

Value of GPSkin for the measurement of skin barrier impairment and for monitoring of rosacea treatment in daily practice

por Logger, Jade G. M., Driessen, Rieke J. B., de Jong, Elke M. G. J., van Erp, Piet E. J.
Publicado 2020

Morphea and Eosinophilic Fasciitis: An Update

por Mertens, Jorre S., Seyger, Marieke M. B., Thurlings, Rogier M., Radstake, Timothy R. D. J., de Jong, Elke M. G. J.
Publicado 2017

Lymphocyte subsets in peripheral blood of patients with moderate-to-severe versus mild plaque psoriasis

por Langewouters, A. M. G., van Erp, P. E. J., de Jong, E. M. G. J., van de Kerkhof, P. C. M.
Publicado 2007

The Effect of Lifestyle Changes on Disease Severity and Quality of Life in Patients with Plaque Psoriasis: A Narrative Review

por van Acht, Maartje R, van den Reek, Juul M P A, de Jong, Elke M G J, Seyger, Marieke M B
Publicado 2022

Image‐based automated Psoriasis Area Severity Index scoring by Convolutional Neural Networks

por Schaap, M.J., Cardozo, N.J., Patel, A., de Jong, E.M.G.J., van Ginneken, B., Seyger, M.M.B.
Publicado 2021

Attitudes and behaviour regarding dose reduction of biologics for psoriasis: a survey among dermatologists worldwide

por van Muijen, M. E., van der Schoot, L. S., van den Reek, J. M. P. A., de Jong, E. M. G. J.
Publicado 2021

Global Risk of Bacterial Skin Infections and Herpesviridae Infections with Ustekinumab, Secukinumab, and Tumour Necrosis Factor-alpha Inhibitors: Spontaneous Reports of Adverse Dru...

por DAVIDSON, Linda, VAN DEN REEK, Juul M. P. A., VAN HUNSEL, Florence, DE JONG, Elke M. G. J., KULLBERG, Bart Jan
Publicado 2022

Regaining adequate treatment responses in patients with psoriasis who discontinued dose reduction of adalimumab, etanercept or ustekinumab

por van der Schoot, Lara S., Atalay, Selma, Otero, Marisol E., Kievit, Wietske, van den Reek, Juul M.P.A., de Jong, Elke M.G.J.
Publicado 2022

Pregnancy Outcomes in Women With Moderate-to-Severe Psoriasis From the Psoriasis Longitudinal Assessment and Registry (PSOLAR)

por Kimball, Alexa B., Guenther, Lyn, Kalia, Sunil, de Jong, Elke M. G. J., Lafferty, Kimberly Parnell, Chen, Dan Y., Langholff, Wayne, Shear, Neil H.
Publicado 2021

Dose Tapering of Biologics in Patients with Psoriasis: A Scoping Review

por Michielsens, C. A. J., van Muijen, M. E., Verhoef, L. M., van den Reek, J. M. P. A., de Jong, E. M. G. J
Publicado 2021

Effect of Age of Onset of Psoriasis on Clinical Outcomes with Systemic Treatment in the Psoriasis Longitudinal Assessment and Registry (PSOLAR)

por Singh, Sanminder, Kalb, Robert E., de Jong, Elke M. G. J., Shear, Neil H., Lebwohl, Mark, Langholff, Wayne, Hopkins, Lori, Srivastava, Bhaskar, Armstrong, April W.
Publicado 2018

Ranking Self-reported Gastrointestinal Side Effects of Pharmacotherapy in Sarcoidosis

por Drent, M., Proesmans, V. L. J., Elfferich, M. D. P., Jessurun, N. T., de Jong, S. M. G., Ebner, N. M., Lewis, E. D. O., Bast, A.
Publicado 2020

The Skin May Clear But the Arthritis Won’t Disappear: Focusing on Concomitant and New-Onset Psoriatic Arthritis in a Daily Practice Cohort of Psoriasis Patients on Biologic Therapy...

por van Muijen, Marloes E, van Hal, Tamara W, Groenewoud, Hans M M, van den Reek, Juul M P A, de Jong, Elke M G J
Publicado 2020

Treatment persistence in paediatric and adolescent patients with psoriasis followed into young adulthood. From topical to systemic treatment: a prospective, longitudinal, observati...

por Bruins, F.M., Bronckers, I.M.G.J., Cai, R., Groenewoud, J.M.M., Krol, M., de Jong, E.M.G.J., Seyger, M.M.B.
Publicado 2020

Unmet Personal Patient Needs in Psoriasis Patients with Low Disease Activity on Adalimumab, Etanercept or Ustekinumab

por van Muijen, Marloes E., Atalay, S., van Vugt, L. J., Vandermaesen, L. M. D., van den Reek, J. M. P. A., de Jong, E. M. G. J.
Publicado 2021

Real-world Methotrexate Use in a Prospective Cohort of Paediatric Patients with Plaque Psoriasis: Effectiveness, Adverse Events and Folic Acid Regimen

por BRUINS, Finola M., VAN ACHT, Maartje R., BRONCKERS, Inge M. G. J., GROENEWOUD, Hans M. M., DE JONG, Elke M. G. J., SEYGER, Marieke M. B.
Publicado 2022

Demography, baseline disease characteristics, and treatment history of psoriasis patients with self-reported psoriatic arthritis enrolled in the PSOLAR registry

por Kavanaugh, Arthur, Papp, Kim, Gottlieb, Alice B., de Jong, Elke M. G. J., Chakravarty, Soumya D., Kafka, Shelly, Langholff, Wayne, Farahi, Kamyar, Srivastava, Bhaskar, Scher, Jose U.
Publicado 2018

Dose reduction of the new generation biologics (IL-17 and IL-23 inhibitors) in psoriasis: study protocol for an international, pragmatic, multicenter, randomized, controlled, non-i...

por van der Schoot, Lara S., van den Reek, Juul M. P. A., Grine, Lynda, Schots, Lisa, Kievit, Wietske, Lambert, Jo L. W., de Jong, Elke M. G. J.
Publicado 2021

Evaluation of a One-step Dose Reduction Strategy of Adalimumab, Etanercept and Ustekinumab in Patients with Psoriasis in Daily Practice

por ATALAY, Selma, VAN DER SCHOOT, Lara S., VANDERMAESEN, Laura, VAN VUGT, Lieke J., EILANDER, Mascha, VAN DEN REEK, Juul M. P. A., DE JONG, Elke M. G. J.
Publicado 2021